NEWTON, Mass., July 24 /PRNewswire/ -- Aspect Medical Systems, Inc. (Nasdaq: ASPM), the world's leading provider of consciousness monitoring technology, has named Ralph Germscheid vice president of sales, announced Nassib Chamoun, president and CEO of Aspect. Germscheid brings more than 20 years of sales and sales management experience in the anesthesia market. He joined Nellcor (acquired by Mallinckrodt in 1998) more than 16 years ago, and began shortly after the company's introduction of pulse oximetry into the anesthesia market. He will be responsible for directing Aspect's sales and distribution organization to expand market penetration of the company's proprietary BIS monitoring system. ( Photo: http://www.newscom.com/cgi-bin/prnh/20000405/ASPMLOGO ) "Ralph brings a strong record of success in conceptual selling of new technologies to the anesthesia community," said Chamoun. "His role in developing the market for pulse oximetry and helping to establish the technology as a standard of care in anesthesia is directly applicable to Aspect's mission. Moreover, Ralph's charismatic style and proven leadership position him well to quickly become an integral part of our organization and further increase the size and scope of our presence in the marketplace." Germscheid joins Aspect with a track record of exceeding sales objectives at Nellcor, Nellcor Puritan Bennett and Mallinckrodt. For the past two years, he served as vice president of sales for Mallinckrodt's alternate care business managing a large team of sales representatives, as well as corporate accounts and customer service. In this position, Germscheid spearheaded programs to integrate and expand the organization, such as the design and implementation of a strategic sales information system. In addition, he established a national network of independent manufacturers representatives to expand product availability for customers. Prior to Mallinckrodt's acquisition of Nellcor Puritan Bennett, Germscheid was western area sales manager responsible for sales and clinical personnel in 26 states. "Aspect is an innovative company with an energetic spirit and a technology that truly makes a difference in patient care," Germscheid stated. "I look forward to leading and empowering the field sales organization to accelerate the market penetration of BIS technology and further improve anesthesia practice." About BIS Monitoring Developed in collaboration with leading anesthesiologists, BIS monitoring enables clinicians to assess and manage the effects of drug dosing in the operating room and intensive care settings. BIS monitoring uses a sensor placed on the forehead to capture EEG signals, which are translated into a single number ranging from 100 (for wide awake) to zero (indicating the absence of brain electrical activity). As a result, BIS monitoring allows clinicians to better determine the amount of drug that each patient needs, thereby helping to prevent over-dosing and under-dosing. In the OR, this enables patients to have a faster and higher quality recovery with fewer post-operative side effects. These benefits are achieved while the provider is able to continuously assess the risk of patient awareness during surgery. In critical care settings, BIS monitoring is used to titrate sedatives and help minimize the clinical and economic consequences of under-sedation and over-sedation. BIS technology is available in Aspect's A-2000(TM) BIS monitor and has been licensed for integration into the majority of patient monitoring and anesthesia delivery systems, including Agilent Technologies, Drager, GE Marquette, Nihon Kohden and Spacelabs Medical. Since its commercial introduction in October 1996, more than 900 healthcare facilities nationwide have adopted the BIS monitor, with more than 8,200 monitors in use and over 1,800,000 patients monitored across the globe. To date, more than 450 peer-reviewed articles and abstracts have been published that document the efficacy, limitations and outcomes benefits of the BIS system. About Aspect Medical Systems, Inc. Aspect Medical Systems, Inc. develops noninvasive monitoring systems to improve the cost effectiveness and quality of patient care. The company's systems utilize innovative, patented, digital signal processing software linked to proprietary sensors. Aspect meets ISO 9001 certification requirements. For more information, visit the company's Web site at http://www.aspectms.com. Certain statements in this release are forward looking and may involve risk and uncertainties, including statements with respect to market acceptance and market penetration. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are the results of clinical trials, the Company's ability to successfully commercialize its products and products under development, the company's ability to achieve and maintain regulatory approval of products under development, the scope of the company's patent protection and other risks included under the heading "Risk Factors" in the company's Quarterly Report on Form 10-Q filed on May 15, 2000, filed with the Securities and Exchange Commission. Bispectral Index and BIS are registered trademarks of Aspect Medical Systems, Inc. A-2000 is a trademark of Aspect Medical Systems, Inc. Contact: Lorie Fiber/Courtney Walker Fischer & Partners, Inc. 310-577-7870 ext. 109/113 email@example.com
SOURCE Aspect Medical Systems, Inc.